Sign In
Buy VRSK
Verisk Analytics Earnings Calls
| Release date | Oct 29, 2025 |
| EPS estimate | $1.70 |
| EPS actual | $1.72 |
| EPS Surprise | 1.18% |
| Revenue estimate | 776.253M |
| Revenue actual | 768.3M |
| Revenue Surprise | -1.02% |
| Release date | Jul 30, 2025 |
| EPS estimate | $1.78 |
| EPS actual | $1.88 |
| EPS Surprise | 5.62% |
| Revenue estimate | 768.726M |
| Revenue actual | 772.6M |
| Revenue Surprise | 0.504% |
| Release date | May 07, 2025 |
| EPS estimate | $1.68 |
| EPS actual | $1.73 |
| EPS Surprise | 2.98% |
| Revenue estimate | 749.825M |
| Revenue actual | 753M |
| Revenue Surprise | 0.423% |
| Release date | Feb 26, 2025 |
| EPS estimate | $1.60 |
| EPS actual | $1.61 |
| EPS Surprise | 0.625% |
| Revenue estimate | 733.698M |
| Revenue actual | 735.6M |
| Revenue Surprise | 0.259% |
Last 4 Quarters for Verisk Analytics
Below you can see how VRSK performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 26, 2025 |
| Price on release | $288.03 |
| EPS estimate | $1.60 |
| EPS actual | $1.61 |
| EPS surprise | 0.625% |
| Date | Price |
|---|---|
| Feb 20, 2025 | $292.70 |
| Feb 21, 2025 | $295.11 |
| Feb 24, 2025 | $297.01 |
| Feb 25, 2025 | $299.72 |
| Feb 26, 2025 | $288.03 |
| Feb 27, 2025 | $290.11 |
| Feb 28, 2025 | $296.91 |
| Mar 03, 2025 | $301.33 |
| Mar 04, 2025 | $299.54 |
| 4 days before | -1.60% |
| 4 days after | 4.00% |
| On release day | 0.722% |
| Change in period | 2.34% |
| Release date | May 07, 2025 |
| Price on release | $309.90 |
| EPS estimate | $1.68 |
| EPS actual | $1.73 |
| EPS surprise | 2.98% |
| Date | Price |
|---|---|
| May 01, 2025 | $294.51 |
| May 02, 2025 | $293.90 |
| May 05, 2025 | $294.75 |
| May 06, 2025 | $296.19 |
| May 07, 2025 | $309.90 |
| May 08, 2025 | $307.85 |
| May 09, 2025 | $309.50 |
| May 12, 2025 | $303.65 |
| May 13, 2025 | $301.57 |
| 4 days before | 5.23% |
| 4 days after | -2.69% |
| On release day | -0.662% |
| Change in period | 2.40% |
| Release date | Jul 30, 2025 |
| Price on release | $275.47 |
| EPS estimate | $1.78 |
| EPS actual | $1.88 |
| EPS surprise | 5.62% |
| Date | Price |
|---|---|
| Jul 24, 2025 | $296.09 |
| Jul 25, 2025 | $297.96 |
| Jul 28, 2025 | $294.43 |
| Jul 29, 2025 | $294.05 |
| Jul 30, 2025 | $275.47 |
| Jul 31, 2025 | $278.71 |
| Aug 01, 2025 | $271.89 |
| Aug 04, 2025 | $268.00 |
| Aug 05, 2025 | $264.72 |
| 4 days before | -6.96% |
| 4 days after | -3.90% |
| On release day | 1.18% |
| Change in period | -10.59% |
| Release date | Oct 29, 2025 |
| Price on release | $208.00 |
| EPS estimate | $1.70 |
| EPS actual | $1.72 |
| EPS surprise | 1.18% |
| Date | Price |
|---|---|
| Oct 23, 2025 | $234.79 |
| Oct 24, 2025 | $234.94 |
| Oct 27, 2025 | $233.68 |
| Oct 28, 2025 | $232.13 |
| Oct 29, 2025 | $208.00 |
| Oct 30, 2025 | $217.60 |
| Oct 31, 2025 | $218.76 |
| Nov 03, 2025 | $215.40 |
| Nov 04, 2025 | $220.00 |
| 4 days before | -11.41% |
| 4 days after | 5.77% |
| On release day | 4.62% |
| Change in period | -6.30% |
Verisk Analytics Earnings Call Transcript Summary of Q3 2025
Verisk reported Q3 2025 results with solid subscription-led growth offset by weak transactional volume due to an unusually light weather quarter. Organic constant-currency (OCC) revenue grew 5.5% driven by subscription revenue growth of 8.7%; transactional revenue declined 8.8% largely from lower claims assignments in Property Estimating Solutions. OCC adjusted EBITDA grew 8.8% with adjusted EBITDA margin expanding to 55.8%. Management emphasized strong sales momentum (2025 on track to be the strongest sales year), continued product innovation (Core Lines Reimagine, Verisk Synergy Studio), and growing commercial adoption of AI-enabled solutions (e.g., XactXpert, XactAI, natural language query tools). The planned AccuLynx acquisition is facing an FTC second request and its expected benefits have been removed from 2025 guidance. Cash flow was robust (operating cash flow $404M; free cash flow $336M), the dividend was raised 15% to $0.45 per share, and $100M of buybacks were executed in the quarter. Updated 2025 guidance (excluding AccuLynx): revenue $3.05B–$3.08B; adjusted EBITDA $1.69B–$1.72B; adjusted EBITDA margin 55%–55.8%; diluted adjusted EPS $6.80–$7.00. Management reiterated confidence in long-term growth (historical organic growth mid-high single digits) and that AI and contributory data initiatives should expand opportunities and pricing/leverage over time.
